Change Language

Select Language

Press Release:

Global Travel Vaccines Market to Reach US$ 8.1 Billion By 2024, Catalyzed by Increasing International Tourism

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global travel vaccines market reached a value of US$ 2.94 Billion in 2020. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.

The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers journey from developed countries to regions with endemic diseases. As more people travel to countries with endemic diseases, the demand for vaccines will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an essential requirement in an international travelers list. For instance, the Ministry of Health in the Kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis and Poliomyelitis must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements and increasing incidence of life-threatening infectious diseases. Looking forward, IMARC Group expects the global travel vaccines market to grow at a CAGR of 8.10% during 2021-2026.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, composition, and disease.

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines


Combination vaccines currently account for the majority of the market share as they are given to travelers in order to protect against multiple diseases.

Breakup by Disease:

  • Hepatitis A 
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others


Amongst these, hepatitis A represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water.

Regional Insights:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America


On the geographical front, North America enjoys the leading position in the market. A large number of companies in the region are introducing a superior range of travel vaccines, including a vaccine against varicella.

Competitive Landscape:

The market is concentrated in nature with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abelló A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Travel Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Composition
    5.5    Market Breakup by Disease 
    5.6    Market Breakup by Region
    5.7    Market Forecast
6    Market Breakup by Composition 
    6.1    Mono Vaccines 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Combination Vaccines 
        6.2.1    Market Trends
        6.2.2    Market Forecast
7    Market Breakup by Disease 
    7.1    Hepatitis A  
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    DPT  
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Yellow Fever
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Typhoid 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Hepatitis B
        7.5.1    Market Trends
        7.5.2    Market Forecast
    7.6    Measles and Mumps
        7.6.1    Market Trends
        7.6.2    Market Forecast
    7.7    Rabies
        7.7.1    Market Trends
        7.7.2    Market Forecast
    7.8    Meningococcal
        7.8.1    Market Trends
        7.8.2    Market Forecast
    7.9    Varicella
        7.9.1    Market Trends
        7.9.2    Market Forecast
    7.10    Japanese Encephalitis
        7.10.1    Market Trends
        7.10.2    Market Forecast
    7.11    Others
        7.11.1    Market Trends
        7.12.2    Market Forecast
8    Market Breakup by Region
    8.1    North America 
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Europe 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Asia Pacific 
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Middle East and Africa
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Latin America
        8.5.1    Market Trends
        8.5.2    Market Forecast
9    Global Travel Vaccines Industry: SWOT Analysis 
    9.1    Overview 
    9.2    Strengths
    9.3    Weaknesses 
    9.4    Opportunities
    9.5    Threats
10    Global Travel Vaccines Industry: Value Chain Analysis 
    10.1    Exploratory Stage
    10.2    Preclinical and Clinical Development
    10.3    Regulatory Approval
    10.4    Manufacturing
    10.5    Marketing and Distribution
11    Global Travel Vaccines Industry: Porters Five Forces Analysis 
    11.1     Overview 
    11.2     Bargaining Power of Buyers
    11.3     Bargaining Power of Suppliers 
    11.4     Degree of Competition
    11.5     Threat of New Entrants
    11.6     Threat of Substitutes
12    Global Travel Vaccines Industry: Price Analysis 
13    Travel Vaccines Manufacturing Process
    13.1    Product Overview
    13.2    Raw Material Requirements
    13.3    Manufacturing Process
    13.4    Key Success and Risk Factors
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    GlaxoSmithKline Pharmaceuticals Limited  
        14.3.2    Sanofi Pasteur  
        14.3.3    Merck & Co., Inc. 
        14.3.4    Novartis AG  
        14.3.5    Pfizer Inc.   
        14.3.6    ALK-Abelló A/S  
        14.3.7    Bavarian Nordic A/S   
        14.3.8    Crucell (Subsidiary of Johnson & Johnson)  
        14.3.9    CSL Limited  
        14.3.10    AstraZeneca PLC  
        14.3.11    Altimmune, Inc.  
        14.3.12    Abbott Laboratories  
        14.3.13    Hoffmann-La Roche, Inc.

List of Figures

Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2020
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2020
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2020
Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
Figure 9: Global: Travel Vaccines Industry: Porter’s Five Forces Analysis
Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Travel Vaccines (DPT) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Travel Vaccines (DPT) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Travel Vaccines (Measles and Mumps) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Travel Vaccines (Measles and Mumps) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Travel Vaccines (Varicella) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Travel Vaccines (Varicella) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Travel Vaccines (Japanese Encephalitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Travel Vaccines (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: North America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Travel Vaccines Manufacturing: Process Flow
 
List of Tables

Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2021-2026
Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2021-2026
Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Travel Vaccines: Raw Material Requirements
Table 6: Global: Travel Vaccines Market Structure
Table 7: Global: Travel Vaccines Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

The global travel vaccines market reached a value of US$ 2.94 Billion in 2020.

According to the estimates by IMARC Group, expects the global travel vaccines market to grow at a CAGR of 8.10% during 2021-2026.

Substantial growth in the travel and tourism industry in recent years, along with the growing prevalence of infectious and travel-related diseases, acts as a major factor driving the market.

Regulatory authorities mandating vaccines for travelers coming from disease-prone regions represents one of the major trends in the market.

The coronavirus disease (COVID-19) has negatively impacted the market growth. This can be accredited to lockdowns imposed by governments of several countries that have halted the domestic and international travel services temporarily.

The market has been bifurcated on the basis of the composition into mono and combination vaccines.

Based on the disease, the market has been segregated into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others.

On the geographical front, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Leading industry players are GlaxoSmithKline Plc, Sanofi Pasteur SA (Sanofi SA), Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Johnson & Johnson, CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories and Hoffmann-La Roche, Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Irritable Bowel Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Immunodiagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links